markets is the sole category represented across all 1 tracked stories. Apimeds Pharmaceuticals US, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. MindChain appears in 1 tracked Finance story from October 6, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about MindChain
markets is the sole category represented across all 1 tracked stories. Apimeds Pharmaceuticals US, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. MindChain appears in 1 tracked Finance story from October 6, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering MindChain. Shared-story counts are live from our verified record — not editorial picks.
Apimeds Pharmaceuticals unit MindWave announced a two-year build-and-operate agreement with BlockAssure to deploy AssureChain, adding quarterly development fees and a 20% AssureCoin allocation. For APUS investors, the deal is a diversification catalyst into insurance-grade blockchain infrastructure, but the token element remains contingent and unverified.
MindChain is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.